StockData

Incannex Healthcare vs Silo Pharma

IXHL and SILO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

ixhlIncannex Healthcare$1.97−82.4% in 1 yearsiloSilo Pharma$1.84−72.8% in 1 year

How IXHL and SILO compare

Incannex Healthcare is the larger company, worth 8.5 times as much as Silo Pharma ($24.7M against $2.9M).

Incannex Healthcare scores higher on the StockData Score (7 against 3 for Silo Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIXHLSILO
Size and price
Market cap$24.7M$2.9M
Share price$1.97$1.84
Change, 1 year−82.4%−72.8%
Change, 5 years–−98.7%
Beta (5Y)1.950.48
Employees123
StockData Score
Total score7 (better)3
Valuation score11
Growth score00
Performance score11
Health score5 (better)1
Dividend score00
Valuation
P/S–81.1×
P/B0.4×0.3× (better)
FCF yield−52.1%–
Growth
Revenue growth (TTM)–−50.0%
Revenue growth, 5Y average–12.0%
Profitability
Operating margin–−12534%
Net margin–−10319%
Return on equity−47.8% (better)−55.3%
Financial health
Debt / equity0.00–
Interest coverage–−112.8×
Current ratio48.81 (better)24.43
Altman Z-score−0.620.87 (better)
Piotroski F-score44
Dividends and buybacks
Buyback yield−280%–
Shareholder yield−280%0.00% (better)
Ownership
Held by institutions3.6%9.0%
Held by insiders–13.8%
Insider net buying, 12 months–$2.1K
Short interest, % of float–1.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.